Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Board Changes

28 May 2026 07:05

RNS Number : 9530F
Johnson Matthey PLC
28 May 2026
 

28th May 2026

Johnson Matthey Plc

(the Company)

Appointment of Julie Southern as a Non-Executive Director and Senior Independent Director and other Board changes

As noted in the Company's results announcement released this morning, Barbara Jeremiah, the Company's Senior Independent Director (SID), and John O'Higgins, chair of the Remuneration Committee, will each retire from the Board with effect from the conclusion of the forthcoming Annual General Meeting (AGM) to be held on 16th July 2026.

As part of the Board's succession planning, and following a comprehensive search and selection process, the appointment of Julie Southern as a NED and the Company's SID was approved by the Board on 27th May 2026. Julie's appointment will be effective from the conclusion of the AGM on 16th July 2026. Upon joining the Board, Julie will also become a member of the Audit Committee and Nomination Committee.

Effective from the conclusion of the AGM on 16th July 2026, Sinead Lynch will become chair of the Remuneration Committee.

Julie is a Chartered Accountant and has significant FTSE Board and C-Suite experience including in finance, strategy, business development and governance.

Julie is currently Chair of NASDAQ listed NXP Semiconductors NV and is Chair of the Remuneration Committee, and also sits on each of the Audit Committee and People Committee, of FTSE 250 Ocado Group plc. She has previously served as Chair of RWS Holding Plc and was Senior Independent Director and Audit Committee Chair of FTSE 100 airline EasyJet Plc.

Andrew Cosslett, Chair of Johnson Matthey said: "On behalf of Johnson Matthey and the whole Board, I would like to thank Barbara and John for their valuable contributions to the Board as non-executive directors and as Senior Independent Director and chair of the Remuneration Committee, respectively. I would also like to welcome Julie to Johnson Matthey. I am delighted that she will be joining the Board and look forward to working with her and the Board benefiting from her expertise and experience."

In accordance with obligations under UKLR 6.4.8R, Julie currently holds, or has held, the following directorships:

Current directorships

NXP Semiconductors NV, a company listed on the NASDAQ Global Select Market (appointed to the Board in October 2013)

Ocado Group plc, a company listed on the London Stock Exchange (appointed to the Board in September 2018)

Previous directorships

RWS Holding Plc, a company listed on the London Stock Exchange (July 2022 - December 2023)

EasyJet Plc, a company listed on the London Stock Exchange (August 2020 - February 2023)

Rentokil Initial Plc, a company listed on the London Stock Exchange (July 2014 - May 2023)

There are no other matters that require disclosure under 6.4.8R of the UK Listing Rules.

 ENDS

Enquiries: 

Simon Price

General Counsel and Company Secretary

+44 20 7269 8052

Louise Curran

Head of Investor Relations

+44 20 7269 8235

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKOBKOBKDQPB
Date   Source Headline
3rd Jun 20269:03 amRNSDirector/PDMR Shareholding
2nd Jun 20264:40 pmRNSDirector/PDMR Shareholding
1st Jun 20264:02 pmRNSHolding(s) in Company
28th May 20267:05 amRNSBoard Changes
28th May 20267:01 amRNSJohnson Matthey acquisition of Cormetech
28th May 20267:00 amRNSJohnson Matthey Full Year Results
14th May 202611:42 amRNSDirector/PDMR Shareholding
16th Apr 202611:51 amRNSDirector/PDMR Shareholding
24th Mar 202611:30 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSDirector Declaration
24th Feb 20263:30 pmRNSDirector/PDMR Shareholding
24th Feb 20269:48 amRNSDirector/PDMR Shareholding
23rd Feb 20265:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20267:00 amRNSUpdate on Catalyst Technologies sale
12th Feb 202612:44 pmRNSDirector/PDMR Shareholding
14th Jan 20262:22 pmRNSDirector/PDMR Shareholding
8th Jan 202610:01 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20254:51 pmRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSDirectorate change
20th Nov 20257:00 amRNSJohnson Matthey Half Year Results
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
24th Oct 202511:29 amRNSHolding(s) in Company
21st Oct 20253:44 pmRNSHolding(s) in Company
13th Oct 202511:55 amRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSFinancial reporting structure and trading update
3rd Oct 202510:23 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSHolding(s) in Company
26th Sep 20255:29 pmRNSHolding(s) in Company
17th Sep 20259:00 amRNSDirector Declaration
15th Sep 20252:37 pmRNSHolding(s) in Company
11th Sep 20254:13 pmRNSDirector/PDMR Shareholding
8th Sep 20256:00 pmRNSHolding(s) in Company
4th Sep 20255:19 pmRNSHolding(s) in Company
2nd Sep 20254:07 pmRNSHolding(s) in Company
29th Aug 202512:05 pmRNSTotal Voting Rights
26th Aug 20252:07 pmRNSDirector/PDMR Shareholding
13th Aug 20254:38 pmRNSDirector/PDMR Shareholding
13th Aug 20251:51 pmRNSDirector/PDMR Shareholding
5th Aug 20255:19 pmRNSHolding(s) in Company
5th Aug 20254:50 pmRNSDirector/PDMR Shareholding
25th Jul 20252:12 pmRNSHolding(s) in Company
23rd Jul 20252:23 pmRNSHolding(s) in Company
18th Jul 202512:07 pmRNSDirector/PDMR Shareholding
18th Jul 20259:18 amRNSHolding(s) in Company
17th Jul 20252:20 pmRNSResult of AGM
17th Jul 20257:00 amRNSAppointment of Andrew Cosslett as Chair
9th Jul 20254:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.